BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7508622)

  • 1. Developmental estrogenization and prostatic neoplasia.
    Santti R; Newbold RR; Mäkelä S; Pylkkänen L; McLachlan JA
    Prostate; 1994; 24(2):67-78. PubMed ID: 7508622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects on prostate cancer: hereditary form, developmental estrogenization and differentiation therapy.
    Sciarra A; Casale P; Di Chirio C; Di Nicola S; Di Silverio F
    Minerva Urol Nefrol; 1998 Sep; 50(3):185-90. PubMed ID: 9842220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of neonatal estrogens on rat prostate development.
    Prins GS; Birch L; Habermann H; Chang WY; Tebeau C; Putz O; Bieberich C
    Reprod Fertil Dev; 2001; 13(4):241-52. PubMed ID: 11800163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of estrogens in normal and abnormal development of the prostate gland.
    Prins GS; Huang L; Birch L; Pu Y
    Ann N Y Acad Sci; 2006 Nov; 1089():1-13. PubMed ID: 17261752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia.
    Walsh PC
    J Urol; 1988 Apr; 139(4):826. PubMed ID: 2451038
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
    Schulze H; Barrack ER
    Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
    Ricke WA; Wang Y; Cunha GR
    Differentiation; 2007 Nov; 75(9):871-82. PubMed ID: 17924963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of tissue steroids in benign hyperplasia and prostate cancer].
    Voigt KD; Bartsch W
    Urologe A; 1987 Nov; 26(6):349-57. PubMed ID: 2448941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conference summary on prostate growth and aging, 13-15 September 2000.
    Brown TR; Lee C
    Prostate; 2001 Jun; 48(1):54-65. PubMed ID: 11391687
    [No Abstract]   [Full Text] [Related]  

  • 12. Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer.
    Matzkin H; Soloway MS
    Prostate; 1993; 22(4):277-90. PubMed ID: 7684523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
    Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
    Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1984; 145():1-25. PubMed ID: 6201871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice.
    Prins GS; Birch L; Couse JF; Choi I; Katzenellenbogen B; Korach KS
    Cancer Res; 2001 Aug; 61(16):6089-97. PubMed ID: 11507058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocrinologic factors in the development of benign prostatic hyperplasia].
    Schweikert HU; Neumann F; Tunn UW
    Urologe A; 1989 Nov; 28(6):317-20. PubMed ID: 2481357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models for the preneoplastic lesions of the prostate.
    Pylkkänen L; Mäkelä S; Santti R
    Eur Urol; 1996; 30(2):243-8. PubMed ID: 8875206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by combination of neonatal estrogen exposure and hormonal treatments at adulthood.
    Yuen MT; Leung LK; Wang J; Wong YC; Chan FL
    Int J Oncol; 2005 Dec; 27(6):1685-95. PubMed ID: 16273225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.